Results 111 to 120 of about 142 (121)

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species

Journal of Fungi (Basel, Switzerland), 2020
Jeffrey Locke, Zoltan Tóth, Andy Borman   +2 more
exaly  

New antifungals development: rezafungin in candidiasis treatment

The Lancet Infectious Diseases
Desnos-Ollivier, Marie, Lanternier, Fanny   +1 more
openaire   +3 more sources

Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects

Clinical Pharmacology in Drug Development, 2020
exaly  

Rezafungin and invasive candida infections: a new game changing antifungal?

The Lancet, 2023
openaire   +2 more sources

Rezafungin Acetate

openaire   +1 more source

Safety Study of Rezafungin to Treat Invasive Fungal Infections

Case Medical Research, 2019
openaire   +1 more source

Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in Adults

Journal of Infectious Diseases
Irum Syed
exaly  

Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofungin

Clinical Microbiology and Infection
Taylor Sandison
exaly  

Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects

Pharmacotherapy
Voon Ong, Ronak Gandhi, Thomas Marbury   +2 more
exaly  

Long-term Safety and Effectiveness of Rezafungin Treatment in Candidemia and Invasive Candidiasis: Results From an Early Access Program in Italy and Germany

Open Forum Infectious Diseases
Elham Khatamzas, Giusy Tiseo, Giulio Viceconte   +2 more
exaly